Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 28842.83 Crore) operating in Pharmaceuticals sector.
Aurobindo Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Export Incentives and Scrap for the year ending 31-Mar-2022.
Financials
For the quarter ended 30-09-2022, the company reported a Consolidated Total Income of Rs 5796.56 Crore, down -7.65 % from last quarter Total Income of Rs 6276.54 Crore and down -4.01 % from last year same quarter Total Income of Rs 6038.50 Crore. Company reported net profit after tax of Rs 411.60 Crore in latest quarter.
Investment Rationale
While the management remain optimistic on its future outlook and maintained guidance, near-term challenges of pricing pressure in US and operational challenge continues, mid-term drivers are complex injectable, biosimilars, respiratory) are intact. Recommend BUY on the stock with TP to Rs600 (12x Sep’24E). The stock trades at 14x and 12x EPS of Rs41.5 and Rs49.6 on FY23/24E.
Promoter/FII Holdings
Promoters held 51.83 per cent stake in the company as of 30-Sep-2022, while FIIs owned 22.43 per cent, DIIs 16.55 per cent.
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price